TY - JOUR
T1 - Role of nitric oxide in substance P-induced vasodilation differs between the coronary and forearm circulation in humans
AU - Tagawa, Tatsuya
AU - Mohri, Masahiro
AU - Tagawa, Hirofumi
AU - Egashira, Kensuke
AU - Shimokawa, Hiroaki
AU - Kuga, Takeshi
AU - Hirooka, Yoshitaka
AU - Takeshita, Akira
PY - 1997/4
Y1 - 1997/4
N2 - It has been shown that substance P causes endothelium-dependent vasodilation in the human coronary and forearm vessels. However, the precise mechanism whereby substance P dilates the coronary and peripheral vasculatures is unknown in humans. The aim of this study was to examine whether the vasodilator effect of substance P is mediated by nitric oxide in the human coronary and forearm vessels. Eight patients with normal coronary angiograms were studied for the measurements of coronary blood flow (intracoronary Doppler guide wire and quantitative coronary arteriography) and forearm blood flow (strain-gauge plethysmography). Intracoronary acetylcholine (10 μg/min for 2 min) and substance P (30 and 90 ng/min for 2 min) increased coronary blood flow from the baseline value. Intracoronary infusion of N(G)-monomethyl-L-arginine (L-NMMA) at 200 μmol significantly attenuated the magnitudes of increase in coronary blood flow induced by both acetylcholine (p < 0.01) and substance P (p < 0.01). Acetylcholine (4, 8, and 16 μg/min for 2 min) also increased forearm blood flow in a dose-dependent manner. Intraarterial L-NMMA (8 μmol/min for 5 min) decreased the magnitudes of increase in forearm blood flow induced by acetylcholine (p < 0.01). L- NMMA at the same dosage decreased the increase in forearm blood flow induced by substance P, but the magnitude of the inhibitory effect of L-NMMA on blood-flow responses to substance P was significantly smaller in the forearm than in coronary vessels. It is suggested that endothelium-derived nitric oxide contributes to substance P-induced vasodilation, and that the contribution of nitric oxide to substance P-induced vasodilation is smaller in the forearm than in coronary circulation.
AB - It has been shown that substance P causes endothelium-dependent vasodilation in the human coronary and forearm vessels. However, the precise mechanism whereby substance P dilates the coronary and peripheral vasculatures is unknown in humans. The aim of this study was to examine whether the vasodilator effect of substance P is mediated by nitric oxide in the human coronary and forearm vessels. Eight patients with normal coronary angiograms were studied for the measurements of coronary blood flow (intracoronary Doppler guide wire and quantitative coronary arteriography) and forearm blood flow (strain-gauge plethysmography). Intracoronary acetylcholine (10 μg/min for 2 min) and substance P (30 and 90 ng/min for 2 min) increased coronary blood flow from the baseline value. Intracoronary infusion of N(G)-monomethyl-L-arginine (L-NMMA) at 200 μmol significantly attenuated the magnitudes of increase in coronary blood flow induced by both acetylcholine (p < 0.01) and substance P (p < 0.01). Acetylcholine (4, 8, and 16 μg/min for 2 min) also increased forearm blood flow in a dose-dependent manner. Intraarterial L-NMMA (8 μmol/min for 5 min) decreased the magnitudes of increase in forearm blood flow induced by acetylcholine (p < 0.01). L- NMMA at the same dosage decreased the increase in forearm blood flow induced by substance P, but the magnitude of the inhibitory effect of L-NMMA on blood-flow responses to substance P was significantly smaller in the forearm than in coronary vessels. It is suggested that endothelium-derived nitric oxide contributes to substance P-induced vasodilation, and that the contribution of nitric oxide to substance P-induced vasodilation is smaller in the forearm than in coronary circulation.
UR - http://www.scopus.com/inward/record.url?scp=0030998832&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030998832&partnerID=8YFLogxK
U2 - 10.1097/00005344-199704000-00017
DO - 10.1097/00005344-199704000-00017
M3 - Article
C2 - 9156366
AN - SCOPUS:0030998832
SN - 0160-2446
VL - 29
SP - 546
EP - 553
JO - Journal of Cardiovascular Pharmacology
JF - Journal of Cardiovascular Pharmacology
IS - 4
ER -